HURA
NASDAQ
US
TuHURA Biosciences, Inc. - Common Stock
$1.41
▼ $-0.21
(-12.96%)
Vol 1.2M
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$45.9M
ROE
-282.2%
D/E
2.94
Beta
0.08
52W
$1–$6
Wall Street Consensus
9 analysts · Apr 20262
Strong Buy
6
Buy
1
Hold
0
Sell
0
Strong Sell
88.9%
Buy Rating
Price Chart
Similar Stocks
QTTB
Q32 Bio Inc
$40.9M
PYXS
Pyxis Oncology Inc
$71.6M
RCEL
AVITA Medical Inc
$105.2M
MCRB
Seres Therapeutics Inc
P/E 25.0
$134.6M
GOSS
Gossamer Bio Inc
$717.5M
ANIX
Anixa Biosciences Inc
$102.7M
ATYR
aTyr Pharma Inc
$76.7M
FBIO
Fortress Biotech Inc
P/E 28.5
$113.6M
GANX
Gain Therapeutics Inc
$123.8M
INO
Inovio Pharmaceuticals Inc
$119.5M
Earnings
Beat rate: 25.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Sep 2025 | $-0.15 | $-0.13 | +$0.02 |
| Jun 2025 | $-0.13 | $-0.21 | $-0.08 |
| Mar 2025 | $-0.10 | $-0.15 | $-0.05 |
| Sep 2023 | $-0.59 | $-1.83 | $-1.24 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -332.2% | -410.3% | -332.2% | -332.2% | -332.2% | -282.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 2.23 | 0.00 | 2.23 | 2.23 | 2.23 | 2.94 |
| Current Ratio | 0.83 | 3.00 | 0.83 | 0.83 | 0.83 | 0.40 |
Key Ratios
ROA (TTM)
-180.4%
P/B
12.1
EPS (TTM)
$-1.55
52W High
$5.50
52W Low
$0.70
$0.70
52-Week Range
$5.50
How does HURA compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
HURA valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
12.1
▲
391%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
HURA profitability vs Biotechnology peers
ROE
-282.2%
▼
319%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-180.4%
▼
286%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
HURA financial health vs Biotechnology peers
D/E ratio
2.9
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
In line
Current ratio
0.4
▼
91%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.1
▼
92%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
HURA fundamentals radar
HURA
Peer median
Industry
HURA profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
HURA vs peers: key metrics
Latest News
No related news yet